Hoth Therapeutics' Corporate Majority Round

Hoth Therapeutics raised a round of funding on June 20, 2017. Investors include Spherix.

Hoth Therapeutics is a development stage biopharmaceutical company focusing on the development of therapeutics for patients suffering from atopic dermatitis, such as eczema.…

Articles about Hoth Therapeutics' Corporate Majority Round: